img

Global Age Related Macular Degeneration Drug Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application


Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Age Related Macular Degeneration Drug Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

Age-related macular degeneration (AMD) is a disease that blurs the sharp, central vision you need for “straight-ahead” activities such as reading, sewing, and driving. AMD affects the macula, the part of the eye that allows you to see fine detail.
Age Related Macular Degeneration Drug report published by QYResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Age Related Macular Degeneration Drug market is projected to reach US$ 11590 million in 2034, increasing from US$ 7725.7 million in 2022, with the CAGR of 5.9% during the period of 2024 to 2034. Demand from Hospitals and Clinics are the major drivers for the industry.
North America is the largest Age Related Macular Degeneration Drug market with about 65% market share. Europe is follower, accounting for about 29% market share.
The key players are Regeneron Pharmaceuticals, Bayer HealthCare, Novartis, Roche, Kanghong Pharma etc. Top 3 companies occupied about 79% market share.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Age Related Macular Degeneration Drug market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report



By Company


Regeneron Pharmaceuticals
Bayer HealthCare
Novartis
Roche
Kanghong Pharma
Segment by Type
Lucentis
Eylea
Avastin
Others

Segment by Application


Hospitals
Clinics
Others

Segment by Region


North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Each chapter of the report provides detailed information for readers to understand the Age Related Macular Degeneration Drug market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Age Related Macular Degeneration Drug, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Age Related Macular Degeneration Drug industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Age Related Macular Degeneration Drug in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Age Related Macular Degeneration Drug introduction, etc. Age Related Macular Degeneration Drug Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13QYResearch’s Conclusions of Age Related Macular Degeneration Drug market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by QYResearch.

Table of Content

1 Age Related Macular Degeneration Drug Market Overview
1.1 Age Related Macular Degeneration Drug Product Overview
1.2 Age Related Macular Degeneration Drug Market Segment by Type
1.2.1 Lucentis
1.2.2 Eylea
1.2.3 Avastin
1.2.4 Others
1.3 Global Age Related Macular Degeneration Drug Market Size by Type
1.3.1 Global Age Related Macular Degeneration Drug Market Size Overview by Type (2018-2034)
1.3.2 Global Age Related Macular Degeneration Drug Historic Market Size Review by Type (2018-2024)
1.3.3 Global Age Related Macular Degeneration Drug Forecasted Market Size by Type (2024-2034)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Age Related Macular Degeneration Drug Sales Breakdown by Type (2018-2024)
1.4.2 Europe Age Related Macular Degeneration Drug Sales Breakdown by Type (2018-2024)
1.4.3 Asia-Pacific Age Related Macular Degeneration Drug Sales Breakdown by Type (2018-2024)
1.4.4 Latin America Age Related Macular Degeneration Drug Sales Breakdown by Type (2018-2024)
1.4.5 Middle East and Africa Age Related Macular Degeneration Drug Sales Breakdown by Type (2018-2024)
2 Global Age Related Macular Degeneration Drug Market Competition by Company
2.1 Global Top Players by Age Related Macular Degeneration Drug Sales (2018-2024)
2.2 Global Top Players by Age Related Macular Degeneration Drug Revenue (2018-2024)
2.3 Global Top Players by Age Related Macular Degeneration Drug Price (2018-2024)
2.4 Global Top Manufacturers Age Related Macular Degeneration Drug Manufacturing Base Distribution, Sales Area, Product Type
2.5 Age Related Macular Degeneration Drug Market Competitive Situation and Trends
2.5.1 Age Related Macular Degeneration Drug Market Concentration Rate (2018-2024)
2.5.2 Global 5 and 10 Largest Manufacturers by Age Related Macular Degeneration Drug Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Age Related Macular Degeneration Drug as of 2022)
2.7 Date of Key Manufacturers Enter into Age Related Macular Degeneration Drug Market
2.8 Key Manufacturers Age Related Macular Degeneration Drug Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Age Related Macular Degeneration Drug Status and Outlook by Region
3.1 Global Age Related Macular Degeneration Drug Market Size and CAGR by Region: 2018 VS 2022 VS 2034
3.2 Global Age Related Macular Degeneration Drug Historic Market Size by Region
3.2.1 Global Age Related Macular Degeneration Drug Sales in Volume by Region (2018-2024)
3.2.2 Global Age Related Macular Degeneration Drug Sales in Value by Region (2018-2024)
3.2.3 Global Age Related Macular Degeneration Drug Sales (Volume & Value) Price and Gross Margin (2018-2024)
3.3 Global Age Related Macular Degeneration Drug Forecasted Market Size by Region
3.3.1 Global Age Related Macular Degeneration Drug Sales in Volume by Region (2024-2034)
3.3.2 Global Age Related Macular Degeneration Drug Sales in Value by Region (2024-2034)
3.3.3 Global Age Related Macular Degeneration Drug Sales (Volume & Value), Price and Gross Margin (2024-2034)
4 Global Age Related Macular Degeneration Drug by Application
4.1 Age Related Macular Degeneration Drug Market Segment by Application
4.1.1 Hospitals
4.1.2 Clinics
4.1.3 Others
4.2 Global Age Related Macular Degeneration Drug Market Size by Application
4.2.1 Global Age Related Macular Degeneration Drug Market Size Overview by Application (2018-2034)
4.2.2 Global Age Related Macular Degeneration Drug Historic Market Size Review by Application (2018-2024)
4.2.3 Global Age Related Macular Degeneration Drug Forecasted Market Size by Application (2024-2034)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Age Related Macular Degeneration Drug Sales Breakdown by Application (2018-2024)
4.3.2 Europe Age Related Macular Degeneration Drug Sales Breakdown by Application (2018-2024)
4.3.3 Asia-Pacific Age Related Macular Degeneration Drug Sales Breakdown by Application (2018-2024)
4.3.4 Latin America Age Related Macular Degeneration Drug Sales Breakdown by Application (2018-2024)
4.3.5 Middle East and Africa Age Related Macular Degeneration Drug Sales Breakdown by Application (2018-2024)
5 North America Age Related Macular Degeneration Drug by Country
5.1 North America Age Related Macular Degeneration Drug Historic Market Size by Country
5.1.1 North America Age Related Macular Degeneration Drug Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
5.1.2 North America Age Related Macular Degeneration Drug Sales in Volume by Country (2018-2024)
5.1.3 North America Age Related Macular Degeneration Drug Sales in Value by Country (2018-2024)
5.2 North America Age Related Macular Degeneration Drug Forecasted Market Size by Country
5.2.1 North America Age Related Macular Degeneration Drug Sales in Volume by Country (2024-2034)
5.2.2 North America Age Related Macular Degeneration Drug Sales in Value by Country (2024-2034)
6 Europe Age Related Macular Degeneration Drug by Country
6.1 Europe Age Related Macular Degeneration Drug Historic Market Size by Country
6.1.1 Europe Age Related Macular Degeneration Drug Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
6.1.2 Europe Age Related Macular Degeneration Drug Sales in Volume by Country (2018-2024)
6.1.3 Europe Age Related Macular Degeneration Drug Sales in Value by Country (2018-2024)
6.2 Europe Age Related Macular Degeneration Drug Forecasted Market Size by Country
6.2.1 Europe Age Related Macular Degeneration Drug Sales in Volume by Country (2024-2034)
6.2.2 Europe Age Related Macular Degeneration Drug Sales in Value by Country (2024-2034)
7 Asia-Pacific Age Related Macular Degeneration Drug by Region
7.1 Asia-Pacific Age Related Macular Degeneration Drug Historic Market Size by Region
7.1.1 Asia-Pacific Age Related Macular Degeneration Drug Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2034
7.1.2 Asia-Pacific Age Related Macular Degeneration Drug Sales in Volume by Region (2018-2024)
7.1.3 Asia-Pacific Age Related Macular Degeneration Drug Sales in Value by Region (2018-2024)
7.2 Asia-Pacific Age Related Macular Degeneration Drug Forecasted Market Size by Region
7.2.1 Asia-Pacific Age Related Macular Degeneration Drug Sales in Volume by Region (2024-2034)
7.2.2 Asia-Pacific Age Related Macular Degeneration Drug Sales in Value by Region (2024-2034)
8 Latin America Age Related Macular Degeneration Drug by Country
8.1 Latin America Age Related Macular Degeneration Drug Historic Market Size by Country
8.1.1 Latin America Age Related Macular Degeneration Drug Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
8.1.2 Latin America Age Related Macular Degeneration Drug Sales in Volume by Country (2018-2024)
8.1.3 Latin America Age Related Macular Degeneration Drug Sales in Value by Country (2018-2024)
8.2 Latin America Age Related Macular Degeneration Drug Forecasted Market Size by Country
8.2.1 Latin America Age Related Macular Degeneration Drug Sales in Volume by Country (2024-2034)
8.2.2 Latin America Age Related Macular Degeneration Drug Sales in Value by Country (2024-2034)
9 Middle East and Africa Age Related Macular Degeneration Drug by Country
9.1 Middle East and Africa Age Related Macular Degeneration Drug Historic Market Size by Country
9.1.1 Middle East and Africa Age Related Macular Degeneration Drug Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
9.1.2 Middle East and Africa Age Related Macular Degeneration Drug Sales in Volume by Country (2018-2024)
9.1.3 Middle East and Africa Age Related Macular Degeneration Drug Sales in Value by Country (2018-2024)
9.2 Middle East and Africa Age Related Macular Degeneration Drug Forecasted Market Size by Country
9.2.1 Middle East and Africa Age Related Macular Degeneration Drug Sales in Volume by Country (2024-2034)
9.2.2 Middle East and Africa Age Related Macular Degeneration Drug Sales in Value by Country (2024-2034)
10 Company Profiles
10.1 Regeneron Pharmaceuticals
10.1.1 Regeneron Pharmaceuticals Company Information
10.1.2 Regeneron Pharmaceuticals Introduction and Business Overview
10.1.3 Regeneron Pharmaceuticals Age Related Macular Degeneration Drug Sales, Revenue and Gross Margin (2018-2024)
10.1.4 Regeneron Pharmaceuticals Age Related Macular Degeneration Drug Products Offered
10.1.5 Regeneron Pharmaceuticals Recent Development
10.2 Bayer HealthCare
10.2.1 Bayer HealthCare Company Information
10.2.2 Bayer HealthCare Introduction and Business Overview
10.2.3 Bayer HealthCare Age Related Macular Degeneration Drug Sales, Revenue and Gross Margin (2018-2024)
10.2.4 Bayer HealthCare Age Related Macular Degeneration Drug Products Offered
10.2.5 Bayer HealthCare Recent Development
10.3 Novartis
10.3.1 Novartis Company Information
10.3.2 Novartis Introduction and Business Overview
10.3.3 Novartis Age Related Macular Degeneration Drug Sales, Revenue and Gross Margin (2018-2024)
10.3.4 Novartis Age Related Macular Degeneration Drug Products Offered
10.3.5 Novartis Recent Development
10.4 Roche
10.4.1 Roche Company Information
10.4.2 Roche Introduction and Business Overview
10.4.3 Roche Age Related Macular Degeneration Drug Sales, Revenue and Gross Margin (2018-2024)
10.4.4 Roche Age Related Macular Degeneration Drug Products Offered
10.4.5 Roche Recent Development
10.5 Kanghong Pharma
10.5.1 Kanghong Pharma Company Information
10.5.2 Kanghong Pharma Introduction and Business Overview
10.5.3 Kanghong Pharma Age Related Macular Degeneration Drug Sales, Revenue and Gross Margin (2018-2024)
10.5.4 Kanghong Pharma Age Related Macular Degeneration Drug Products Offered
10.5.5 Kanghong Pharma Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Age Related Macular Degeneration Drug Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Age Related Macular Degeneration Drug Industrial Chain Analysis
11.4 Age Related Macular Degeneration Drug Market Dynamics
11.4.1 Age Related Macular Degeneration Drug Industry Trends
11.4.2 Age Related Macular Degeneration Drug Market Drivers
11.4.3 Age Related Macular Degeneration Drug Market Challenges
11.4.4 Age Related Macular Degeneration Drug Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Age Related Macular Degeneration Drug Distributors
12.3 Age Related Macular Degeneration Drug Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer

List of Figure

List of Tables
Table 1. Major Company of Lucentis
Table 2. Major Company of Eylea
Table 3. Major Company of Avastin
Table 4. Major Company of Others
Table 5. Global Age Related Macular Degeneration Drug Sales by Type 2018 VS 2022 VS 2034 (US$ Million)
Table 6. Global Age Related Macular Degeneration Drug Sales by Type (2018-2024) & (K Units)
Table 7. Global Age Related Macular Degeneration Drug Sales Market Share in Volume by Type (2018-2024)
Table 8. Global Age Related Macular Degeneration Drug Sales by Type (2018-2024) & (US& Million)
Table 9. Global Age Related Macular Degeneration Drug Market Share in Value by Type (2018-2024)
Table 10. Global Age Related Macular Degeneration Drug Price by Type (2018-2024) & (USD/Unit)
Table 11. Global Age Related Macular Degeneration Drug Sales by Type (2024-2034) & (K Units)
Table 12. Global Age Related Macular Degeneration Drug Sales Market Share in Volume by Type (2024-2034)
Table 13. Global Age Related Macular Degeneration Drug Sales by Type (2024-2034) & (US$ Million)
Table 14. Global Age Related Macular Degeneration Drug Sales Market Share in Value by Type (2024-2034)
Table 15. Global Age Related Macular Degeneration Drug Price by Type (2024-2034) & (USD/Unit)
Table 16. North America Age Related Macular Degeneration Drug Sales by Type (2018-2024) & (K Units)
Table 17. North America Age Related Macular Degeneration Drug Sales by Type (2018-2024) & (US$ Million)
Table 18. Europe Age Related Macular Degeneration Drug Sales (K Units) by Type (2018-2024)
Table 19. Europe Age Related Macular Degeneration Drug Sales by Type (2018-2024) & (US$ Million)
Table 20. Asia-Pacific Age Related Macular Degeneration Drug Sales (K Units) by Type (2018-2024)
Table 21. Asia-Pacific Age Related Macular Degeneration Drug Sales by Type (2018-2024) & (US$ Million)
Table 22. Latin America Age Related Macular Degeneration Drug Sales (K Units) by Type (2018-2024)
Table 23. Latin America Age Related Macular Degeneration Drug Sales by Type (2018-2024) & (US$ Million)
Table 24. Middle East and Africa Age Related Macular Degeneration Drug Sales (K Units) by Type (2018-2024)
Table 25. Middle East and Africa Age Related Macular Degeneration Drug Sales by Type (2018-2024) & (US$ Million)
Table 26. Global Age Related Macular Degeneration Drug Sales by Company (2018-2024) & (K Units)
Table 27. Global Age Related Macular Degeneration Drug Sales Share by Company (2018-2024)
Table 28. Global Age Related Macular Degeneration Drug Revenue by Company (2018-2024) & (US$ Million)
Table 29. Global Age Related Macular Degeneration Drug Revenue Share by Company (2018-2024)
Table 30. Global Market Age Related Macular Degeneration Drug Price by Company (2018-2024) & (USD/Unit)
Table 31. Global Age Related Macular Degeneration Drug Top Manufacturers Manufacturing Base Distribution and Sales Area
Table 32. Global Age Related Macular Degeneration Drug Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 33. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Age Related Macular Degeneration Drug as of 2022)
Table 34. Date of Key Manufacturers Enter into Age Related Macular Degeneration Drug Market
Table 35. Key Manufacturers Age Related Macular Degeneration Drug Product Type
Table 36. Mergers & Acquisitions, Expansion Plans
Table 37. Global Age Related Macular Degeneration Drug Market Size Comparison by Region (US$ Million): 2018 VS 2022 VS 2034
Table 38. Global Age Related Macular Degeneration Drug Sales by Region (2018-2024) & (K Units)
Table 39. Global Age Related Macular Degeneration Drug Sales Market Share in Volume by Region (2018-2024)
Table 40. Global Age Related Macular Degeneration Drug Sales by Region (2018-2024) & (US$ Million)
Table 41. Global Age Related Macular Degeneration Drug Sales Market Share in Value by Region (2018-2024)
Table 42. Global Age Related Macular Degeneration Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 43. Global Age Related Macular Degeneration Drug Sales by Region (2024-2034) & (K Units)
Table 44. Global Age Related Macular Degeneration Drug Sales Market Share in Volume by Region (2024-2034)
Table 45. Global Age Related Macular Degeneration Drug Sales by Region (2024-2034) & (US$ Million)
Table 46. Global Age Related Macular Degeneration Drug Sales Market Share in Value by Region (2024-2034)
Table 47. Global Age Related Macular Degeneration Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2024-2034)
Table 48. Global Age Related Macular Degeneration Drug Sales by Application: 2018 VS 2022 VS 2034 (US$ Million)
Table 49. Global Age Related Macular Degeneration Drug Sales by Application (2018-2024) & (K Units)
Table 50. Global Age Related Macular Degeneration Drug Sales Market Share in Volume by Application (2018-2024)
Table 51. Global Age Related Macular Degeneration Drug Sales by Application (2018-2024) & (US$ Million)
Table 52. Global Age Related Macular Degeneration Drug Sales Market Share in Value by Application (2018-2024)
Table 53. Global Age Related Macular Degeneration Drug Price by Application (2018-2024) & (USD/Unit)
Table 54. Global Age Related Macular Degeneration Drug Sales by Application (2024-2034) & (K Units)
Table 55. Global Age Related Macular Degeneration Drug Sales Market Share in Volume by Application (2024-2034)
Table 56. Global Age Related Macular Degeneration Drug Sales by Application (2024-2034) & (US$ Million)
Table 57. Global Age Related Macular Degeneration Drug Sales Market Share in Value by Application (2024-2034)
Table 58. Global Age Related Macular Degeneration Drug Price by Application (2024-2034) & (USD/Unit)
Table 59. North America Age Related Macular Degeneration Drug Sales by Application (2018-2024) (K Units)
Table 60. North America Age Related Macular Degeneration Drug Sales by Application (2018-2024) & (US$ Million)
Table 61. Europe Age Related Macular Degeneration Drug Sales by Application (2018-2024) (K Units)
Table 62. Europe Age Related Macular Degeneration Drug Sales by Application (2018-2024) & (US$ Million)
Table 63. Asia-Pacific Age Related Macular Degeneration Drug Sales by Application (2018-2024) (K Units)
Table 64. Asia-Pacific Age Related Macular Degeneration Drug Sales by Application (2018-2024) & (US$ Million)
Table 65. Latin America Age Related Macular Degeneration Drug Sales by Application (2018-2024) (K Units)
Table 66. Latin America Age Related Macular Degeneration Drug Sales by Application (2018-2024) & (US$ Million)
Table 67. Middle East and Africa Age Related Macular Degeneration Drug Sales by Application (2018-2024) (K Units)
Table 68. Middle East and Africa Age Related Macular Degeneration Drug Sales by Application (2018-2024) & (US$ Million)
Table 69. North America Age Related Macular Degeneration Drug Sales by Country (2018-2024) & (K Units)
Table 70. North America Age Related Macular Degeneration Drug Sales Market Share in Volume by Country (2018-2024)
Table 71. North America Age Related Macular Degeneration Drug Sales by Country (2018-2024) & (US$ Million)
Table 72. North America Age Related Macular Degeneration Drug Sales Market Share in Value by Country (2018-2024)
Table 73. North America Age Related Macular Degeneration Drug Sales by Country (2024-2034) & (K Units)
Table 74. North America Age Related Macular Degeneration Drug Sales Market Share in Volume by Country (2024-2034)
Table 75. North America Age Related Macular Degeneration Drug Sales by Country (2024-2034) & (US$ Million)
Table 76. North America Age Related Macular Degeneration Drug Sales Market Share in Value by Country (2024-2034)
Table 77. Europe Age Related Macular Degeneration Drug Sales by Country (2018-2024) & (K Units)
Table 78. Europe Age Related Macular Degeneration Drug Sales Market Share in Volume by Country (2018-2024)
Table 79. Europe Age Related Macular Degeneration Drug Sales by Country (2018-2024) & (US$ Million)
Table 80. Europe Age Related Macular Degeneration Drug Sales Market Share in Value by Country (2018-2024)
Table 81. Europe Age Related Macular Degeneration Drug Sales by Country (2024-2034) & (K Units)
Table 82. Europe Age Related Macular Degeneration Drug Sales Market Share in Volume by Country (2024-2034)
Table 83. Europe Age Related Macular Degeneration Drug Sales by Country (2024-2034) & (US$ Million)
Table 84. Europe Age Related Macular Degeneration Drug Sales Market Share in Value by Country (2024-2034)
Table 85. Asia-Pacific Age Related Macular Degeneration Drug Sales by Region (2018-2024) & (K Units)
Table 86. Asia-Pacific Age Related Macular Degeneration Drug Sales Market Share in Volume by Region (2018-2024)
Table 87. Asia-Pacific Age Related Macular Degeneration Drug Sales by Region (2018-2024) & (US$ Million)
Table 88. Asia-Pacific Age Related Macular Degeneration Drug Sales Market Share in Value by Region (2018-2024)
Table 89. Asia-Pacific Age Related Macular Degeneration Drug Sales by Region (2024-2034) & (K Units)
Table 90. Asia-Pacific Age Related Macular Degeneration Drug Sales Market Share in Volume by Region (2024-2034)
Table 91. Asia-Pacific Age Related Macular Degeneration Drug Sales by Region (2024-2034) & (US$ Million)
Table 92. Asia-Pacific Age Related Macular Degeneration Drug Sales Market Share in Value by Region (2024-2034)
Table 93. Latin America Age Related Macular Degeneration Drug Sales by Country (2018-2024) & (K Units)
Table 94. Latin America Age Related Macular Degeneration Drug Sales Market Share in Volume by Country (2018-2024)
Table 95. Latin America Age Related Macular Degeneration Drug Sales by Country (2018-2024) & (US$ Million)
Table 96. Latin America Age Related Macular Degeneration Drug Sales Market Share in Value by Country (2018-2024)
Table 97. Latin America Age Related Macular Degeneration Drug Sales by Country (2024-2034) & (K Units)
Table 98. Latin America Age Related Macular Degeneration Drug Sales Market Share in Volume by Country (2024-2034)
Table 99. Latin America Age Related Macular Degeneration Drug Sales by Country (2024-2034) & (US$ Million)
Table 100. Latin America Age Related Macular Degeneration Drug Sales Market Share in Value by Country (2024-2034)
Table 101. Middle East and Africa Age Related Macular Degeneration Drug Sales by Country (2018-2024) & (K Units)
Table 102. Middle East and Africa Age Related Macular Degeneration Drug Sales Market Share in Volume by Country (2018-2024)
Table 103. Middle East and Africa Age Related Macular Degeneration Drug Sales by Country (2018-2024) & (US$ Million)
Table 104. Middle East and Africa Age Related Macular Degeneration Drug Sales Market Share in Value by Country (2018-2024)
Table 105. Middle East and Africa Age Related Macular Degeneration Drug Sales by Country (2024-2034) & (K Units)
Table 106. Middle East and Africa Age Related Macular Degeneration Drug Sales Market Share in Volume by Country (2024-2034)
Table 107. Middle East and Africa Age Related Macular Degeneration Drug Sales by Country (2024-2034) & (US$ Million)
Table 108. Middle East and Africa Age Related Macular Degeneration Drug Sales Market Share in Value by Country (2024-2034)
Table 109. Regeneron Pharmaceuticals Company Information
Table 110. Regeneron Pharmaceuticals Introduction and Business Overview
Table 111. Regeneron Pharmaceuticals Age Related Macular Degeneration Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 112. Regeneron Pharmaceuticals Age Related Macular Degeneration Drug Product
Table 113. Regeneron Pharmaceuticals Recent Development
Table 114. Bayer HealthCare Company Information
Table 115. Bayer HealthCare Introduction and Business Overview
Table 116. Bayer HealthCare Age Related Macular Degeneration Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 117. Bayer HealthCare Age Related Macular Degeneration Drug Product
Table 118. Bayer HealthCare Recent Development
Table 119. Novartis Company Information
Table 120. Novartis Introduction and Business Overview
Table 121. Novartis Age Related Macular Degeneration Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 122. Novartis Age Related Macular Degeneration Drug Product
Table 123. Novartis Recent Development
Table 124. Roche Company Information
Table 125. Roche Introduction and Business Overview
Table 126. Roche Age Related Macular Degeneration Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 127. Roche Age Related Macular Degeneration Drug Product
Table 128. Roche Recent Development
Table 129. Kanghong Pharma Company Information
Table 130. Kanghong Pharma Introduction and Business Overview
Table 131. Kanghong Pharma Age Related Macular Degeneration Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 132. Kanghong Pharma Age Related Macular Degeneration Drug Product
Table 133. Kanghong Pharma Recent Development
Table 134. Key Raw Materials Lists
Table 135. Raw Materials Key Suppliers Lists
Table 136. Age Related Macular Degeneration Drug Market Trends
Table 137. Age Related Macular Degeneration Drug Market Drivers
Table 138. Age Related Macular Degeneration Drug Market Challenges
Table 139. Age Related Macular Degeneration Drug Market Restraints
Table 140. Age Related Macular Degeneration Drug Distributors List
Table 141. Age Related Macular Degeneration Drug Downstream Customers
Table 142. Research Programs/Design for This Report
Table 143. Key Data Information from Secondary Sources
Table 144. Key Data Information from Primary Sources
List of Figures
Figure 1. Age Related Macular Degeneration Drug Product Picture
Figure 2. Global Age Related Macular Degeneration Drug Market Size, 2018 VS 2022 VS 2034 (US$ Million)
Figure 3. Global Age Related Macular Degeneration Drug Market Size Status and Outlook (2018-2034) & (US$ Million)
Figure 4. Global Age Related Macular Degeneration Drug Sales Status and Outlook (2018-2034) & (K Units)
Figure 5. Product Picture of Lucentis
Figure 6. Global Lucentis Sales YoY Growth (2018-2034) & (K Units)
Figure 7. Product Picture of Eylea
Figure 8. Global Eylea Sales YoY Growth (2018-2034) & (K Units)
Figure 9. Product Picture of Avastin
Figure 10. Global Avastin Sales YoY Growth (2018-2034) & (K Units)
Figure 11. Product Picture of Others
Figure 12. Global Others Sales YoY Growth (2018-2034) & (K Units)
Figure 13. Global Age Related Macular Degeneration Drug Sales by Type (2018-2034) & (US$ Million)
Figure 14. Global Age Related Macular Degeneration Drug Sales Market Share by Type in 2022 & 2034
Figure 15. North America Age Related Macular Degeneration Drug Sales Market Share in Volume by Type in 2022
Figure 16. North America Age Related Macular Degeneration Drug Sales Market Share in Value by Type in 2022
Figure 17. Europe Age Related Macular Degeneration Drug Sales Market Share in Volume by Type in 2022
Figure 18. Europe Age Related Macular Degeneration Drug Sales Market Share in Value by Type in 2022
Figure 19. Asia-Pacific Age Related Macular Degeneration Drug Sales Market Share in Volume by Type in 2022
Figure 20. Asia-Pacific Age Related Macular Degeneration Drug Sales Market Share in Value by Type in 2022
Figure 21. Latin America Age Related Macular Degeneration Drug Sales Market Share in Volume by Type in 2022
Figure 22. Latin America Age Related Macular Degeneration Drug Sales Market Share in Value by Type in 2022
Figure 23. Middle East and Africa Age Related Macular Degeneration Drug Sales Market Share in Volume by Type in 2022
Figure 24. Middle East and Africa Age Related Macular Degeneration Drug Sales Market Share in Value by Type in 2022
Figure 25. The 5 and 10 Largest Manufacturers in the World: Market Share by Age Related Macular Degeneration Drug Sales in 2022
Figure 26. The 5 and 10 Largest Manufacturers in the World: Market Share by Age Related Macular Degeneration Drug Revenue in 2022
Figure 27. Age Related Macular Degeneration Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 28. Product Picture of Hospitals
Figure 29. Global Hospitals Sales YoY Growth (2018-2034) & (K Units)
Figure 30. Product Picture of Clinics
Figure 31. Global Clinics Sales YoY Growth (2018-2034) & (K Units)
Figure 32. Product Picture of Others
Figure 33. Global Others Sales YoY Growth (2018-2034) & (K Units)
Figure 34. Global Age Related Macular Degeneration Drug Sales by Application (2018-2034) & (US$ Million)
Figure 35. Global Age Related Macular Degeneration Drug Sales Market Share by Application in 2022 & 2034
Figure 36. North America Age Related Macular Degeneration Drug Sales Market Share in Volume by Application in 2022
Figure 37. North America Age Related Macular Degeneration Drug Sales Market Share in Value by Application in 2022
Figure 38. Europe Age Related Macular Degeneration Drug Sales Market Share in Volume by Application in 2022
Figure 39. Europe Age Related Macular Degeneration Drug Sales Market Share in Value by Application in 2022
Figure 40. Asia-Pacific Age Related Macular Degeneration Drug Sales Market Share in Volume by Application in 2022
Figure 41. Asia-Pacific Age Related Macular Degeneration Drug Sales Market Share in Value by Application in 2022
Figure 42. Latin America Age Related Macular Degeneration Drug Sales Market Share in Volume by Application in 2022
Figure 43. Latin America Age Related Macular Degeneration Drug Sales Market Share in Value by Application in 2022
Figure 44. Middle East and Africa Age Related Macular Degeneration Drug Sales Market Share in Value by Application in 2022
Figure 45. Key Raw Materials Price
Figure 46. Age Related Macular Degeneration Drug Manufacturing Cost Structure
Figure 47. Age Related Macular Degeneration Drug Industrial Chain Analysis
Figure 48. Channels of Distribution
Figure 49. Distributors Profiles
Figure 50. Bottom-up and Top-down Approaches for This Report
Figure 51. Data Triangulation
Figure 52. Key Executives Interviewed